Drug intelligence / Profile preview

esat6-cfp10 + tuberculin purified protein derivative

Development stage
Unknown
Lead developer
Zhifei Longcom Biologic Pharmacy
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intradermal
01

Overview

esat6-cfp10 + tuberculin purified protein derivative is a combination of two diagnostic reagents used for the detection of Mycobacterium tuberculosis infection. Tuberculin purified protein derivative (PPD) is a mixture of proteins derived from M. tuberculosis, traditionally used in the Mantoux skin test to detect latent or active tuberculosis infection by eliciting a delayed-type hypersensitivity (DTH) response[1][3]. ESAT6-CFP10 is a recombinant fusion protein composed of two highly immunogenic antigens, Early Secreted Antigenic Target 6 kDa (ESAT-6) and Culture Filtrate Protein 10 kDa (CFP10), which are absent in BCG vaccine strains and most non-tuberculosis mycobacteria[2][3]. This combination aims to improve specificity and sensitivity for TB diagnosis compared to PPD alone, as ESAT6-CFP10 can distinguish M. tuberculosis infection from BCG vaccination and environmental mycobacterial exposure[8][3]. Both components act as skin test reagents that stimulate T-cell mediated immune responses at the site of injection; their combined use may enhance diagnostic accuracy for TB.

Brand names
Yi KaEkear
Other names
ESAT-6-CFP10ESAT6-CFP10ESAT 6-CFP10PPDPurified Protein DerivativeRecombinant ESAT6-CFP10 fusion protein
02

Targets

γδ TCR (T-cell receptor)

Beyond the preview

Go deeper on esat6-cfp10 + tuberculin purified protein derivative.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on esat6-cfp10 + tuberculin purified protein derivative.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call